2nd Edition of International Conference on Gastroenterology

The best of all worlds for gastroenterologists is in peril. The deluge of new, relevant information that inundated medicine precipitated its fragmentation into progressive smaller subunits. Within the realignment of patient governance came with a reduction of its corresponding patient base.

Artificial Intelligence (AI) stands to cause an even more radical restructuring of both traditional medical disciplines and the progressively developing areas of medical sub specialization. AI will render detachable additional areas of limited patient care from their governing discipline and potential subsequent assimilation by medical entities in need of patient additions. AI stands to incorporate known previously unidentified medical facts into constructive disease synthesis. At some point, any healthcare entity that possesses 10 grams of feces and five cc of serum can extract, via AI, the critical necessary information for identification of disease causation and of therapeutic intervention points.

Knowledge is power. This conference is more than an added presentation of developing knowledge within gastroenterology. Embedded in Gastro 2026 is a sincere admonition as to things that, if not genuinely addressed, stands going forward to undermine the fiscal well-being of gastroenterologists. One can disregard the messenger, but not the developing facts in progressive evidence.

Their use is contingent upon documentation of the validity of the Gastro 2026 as an educational event and my participation as Keynote Speaker.

2nd Edition of International Conference on Gastroenterology | London, UK

Dear Colleagues and Attendees,

It is a genuine honor to welcome you to the International Conference on Gastroenterology. As an educational psychologist—not a physician or bench researcher - I arrive with deep respect for the scientific rigor, clinical expertise, and innovation that define this field and this conference. Your work advances not only knowledge, but the daily lived experience of patients and families worldwide.

I am especially excited for the conversations that happen at the intersections: brain-gut communication, stress physiology, behavior change, adherence, and the human factors that shape outcomes alongside biomarkers and procedures. My hope is that this conference sparks fresh collaborations, practical takeaways, and a renewed sense of shared purpose.

Wishing you an inspiring, evidence-rich, and collegial conference.

2nd Edition of International Conference on Gastroenterology, September 24-26, 2026, London

Hello and welcome to anyone who is interested in our session at Gastro 2026 on the subject of medicine of the stomach and upper gut. It’s a vast subject but a major topic will be the huge un-met need for better ways of measuring motility. Not only is gastric motility greatly underdiagnosed, but we lack ways of testing medicines for our patients and monitoring their effect. When AI was asked about measuring it recently, the answer was:

“Gastroparesis and gastric motility disorders affect millions of patients worldwide, but the diagnostic toolkit hasn’t meaningfully advanced in decades. Gastric emptying scintigraphy —the current clinical standard — requires radioactive tracers, nuclear medicine facilities, and multi-hour hospital visits. Breath tests provide limited functional insight. The wireless motility capsule category is in transition following SmartPill’s discontinuation by Medtronic in 2023, with emerging replacements still establishing clinical adoption.

The result: gastroparesis remains significantly underdiagnosed, and even diagnosed patients are rarely monitored longitudinally because repeat testing is too burdensome and expensive”.

So, to detect dysmotility and how well medicines work we need practical, non-invasive ways to measure the stomach. They are in development as I write this. AI powered derivatives of electro-gastrography are improving the detection and interpretation of the diagnostic currents emitted by gastric muscle. Epigastric impedance is having a renaissance. Our session at Gastro 2026 will report on how far these potential advances have progressed.

2nd Edition of International Conference on Gastroenterology | September 24-26, 2026

I have the pleasure and the honor to welcome all of you in this new edition of GASTRO – 2026. We cannot ignore the drums of war sounding across the world, and we must not forget that our role is to improve the health and quality of life of the people of this planet.  My presentation will highlight epidemiolocal progress in comprehension of gallstones, biliary and pancreatic disease during and after pregnancy. Furthermore, we propose prevention and noninvasive therapy for diseases that can endanger the lives of Mathers and their newborn. I hope you will appreciate the valuable message that epidemiology can offer in understanding disease mechanisms and proposing their prevention and treatment. I wish you good work and good time for the Conference and enjoy London.

2nd Edition of International Conference on Gastroenterology | September 24-26, 2026 | London, UK

Thank you for inviting me to be a speaker at your interesting Conference.
I have been studying gastrointestinal pathology for over 50 years, related to thyroid function and more specifically to iodine/iodide itself. I have conducted many studies on the correlation with gastric cancer, which I believe have yielded interesting new insights. However, as you well know, gastric cancer is declining sharply worldwide, and I believe this topic has not attracted much interest in gastrointestinal research. For about 7-8 years, I have been interested in pancreatic pathology, which, based on my previous research in nuclear medicine, I believe is closely related to radionuclides, which I had already been interested in for years. Regarding Iodine-131, about 10 years ago I began to become interested in the frightening increase in pancreatic cancer, which killed my father and twin brother. In autoradiographs, I accidentally found a nearly unknown cesium-137 autoradio graphies by Nelson from 1961, which contradicted what was erroneously known about pancreatic and salivary cesium great concentration. From this point, I began my research on the pancreas, also stimulated by Russian researchers, very interested in this pathology and in the damage caused by Chernobyl radioactivity (Prof. L. Churilov), with whom we are writing a major article for the 40th anniversary of the major nuclear accident, which is partly kept secret by the Nations involved in the development of nuclear power plants. This is why I was interested in this study on the correlation between Cesium-137 Pancreas and Diabetes. I proposed this hypothesis, which is attracting interest from many researchers around the world. However, it is obviously opposed by the WHO, IAEA, FDA-USA, NCI, NIH, and all the government agencies for which these studies naturally cause major social, political, economic, and energetic problems, etc. With this, I great you and wish you great success at your conference.

2nd Edition of International Conference on Gastroenterology | London

My sick fund changed its name to Health Maintenance Organization as it is obvious that lifestyle determines health. Israel has the appropriate data to research the impact of nutrition on health. Only about half of the population was born in Israel. Since the establishment of the state in 1948, we have experienced waves of immigration from all corners of the world. Waves of immigration arrived from Yemen, Morocco, the former Soviet Union, and Ethiopia. The immigrants changed the food they ate in their countries of origin, and several studies tracked the changes in their health over their years of living in the country.

Our study tracked the demographic structure of Kibbutz members. This refers to rural settlements of groups with a shared ideology who lived in communes, mostly located in rural areas. The groups established Kibbutzim where they lived in communes, just like a family. They had a communal dining hall, a single laundry room, and communal children's quarters. The children spent time with their parents for only an hour in the afternoon and returned to their quarters for dinner and bedtime.

In the 1980s, reforms occurred in the structure of the Kibutzim after they fell into heavy debt due to rising interest rates. The change in government led them to an agreement that required detailed reporting on the condition of the elderly, who were at risk of being left without sources of income. As a condition for government assistance to Kibbutzim facing bankruptcy, a dedicated pension fund was established for Kibbutz members. From this pension fund, we learned about the demographic structure of Kibbutz members. The most prominent finding is the long life expectancy of the members. Part of the explanation is the communal dining hall in the Kibbutz. Working in the dining hall was considered a highly prestigious role, and dining hall managers underwent training courses within the Kibbutz Movement. Most of the food was raised and supplied by the Kibbutz, meaning its quality and quantity were supervised by professionals. During the austerity period, Kibbutz children received food of better quality and quantity than children in the cities.

2nd Edition of International Conference on Gastroenterology | London, UK | September 24-26, 2026

Dear delegates, it's an honour for me to express my gratitude to the organising team of the conference Gastro 2026. Gut eventually came up as the most dynamic organ of the body controlling not only the brain but every organ and specially the immune system. Gastro research is in infancy as each of its part acts like a seperate organ with different functions, environment, structure and regulations, but overall regulating the homeostasis of the body. The unique gut microbiome, with entire set of their genes regulate the diseases. Hope this conference brings out holistic approach towards Gastrointestinal research. Best wishes to all the delighted and the organisers.